Cosmo FirstQ1 FY27
Cosmo First Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹924P/E: 14.1Market Cap: ₹2.4K CrSector: Industrial Products
Management growth scorecard
Revenue
Category 2
Margin
Category 1
Fundraise
N/A
Order
N/A
Capex
Yes
2 of 3 growth signals are positive.
Full analysisRevenue guidance
Category 2- →Overall business revenue expected to grow by 20% in the current year (FY27).
- →New businesses projected to grow at 60% in the current year.
- →Specialty film sales aimed to increase to 35%-40% gross margins with scaling revenue, though this will take time.
- →Cosmo Consumer business expected to grow rapidly, with over 3x growth projected this year in the domestic market.
- →Zigly is scaling with a current run rate of ~Rs. 100 crores annualized and targets breakeven at Rs. 250 crores revenue in next couple of years.
- →Plastech business projected to grow from Rs. 100 crores last year to Rs. 150-160 crores this year and ~Rs. 200+ crores next year, with improving margins and ROCE.
- →US market expected to grow 25%-30% this year post duty rationalization, supporting export volume growth.
- →15% unused capacity in films and specialty products expected to be utilized in coming quarters, supporting volume growth.
Margin guidance
Category 1- →Overall company revenue expected to grow by at least 20% in the current year (FY27).
- →New businesses projected to grow at a rapid pace of around 60% this year.
- →Specialty chemical business expected to grow ~50% with 25% EBITDA margins.
- →Plastech business turned profitable in Q1 FY27; targeting double-digit profitability by year-end and aiming for 15%-20%+ ROCE as it scales to Rs. 300-350 crores revenue.
- →Cosmo Consumer close to breakeven at EBITDA level with potential to be profitable before Rs. 100 crores revenue.
- →Zigly breakeven expected around Rs. 250 crores revenue, though profitability may take 2+ years.
- →EBITDA growth of 26% on 9% volume growth indicates improving margins.
- →ROCE targeted to improve from ~11% to 15%-20% over next 12-24 months driven by volume growth, specialty sales, and cost efficiencies.
- →Specialty films gross margins targeted at 35%-40% with scaling revenues.
3 more insights locked — sign up free to unlock
Fundraise plans
- →Management did not explicitly mention any current or planned fundraising through debt or equity in the call.
- →They emphasized reducing corporate net debt substantially over the next 2 years.
- →Target is to reduce net debt to EBITDA ratio below 2x within 12 months primarily through EBITDA growth and net debt repayment via internal accruals.
- →Capex containment is planned to support debt reduction.
- →No mention of raising fresh capital through equity or debt instruments as part of growth or expansion plans.
- →Focus remains on improving ROCE, scaling new businesses, and financial resilience without additional fundraising.
Order book
The transcript does not explicitly mention current or expected order book or pending orders for Cosmo First Limited. However, relevant insights include:
- Specialty films and new businesses like Cosmo Specialty Chemicals, Plastech, and Cosmo Consumer are scaling up rapidly.
- The company is expecting overall business growth of 20% this year; new businesses are growing at 60%.
- Film business has about 15% spare capacity expected to be utilized in coming quarters.
- Specialty film sales grew 12% this quarter, with new product launches and patents in pipeline.
- Export markets, including U.S., expected to grow 25%-30% this year post-duty rationalization.
- The company continues to invest in scaling and expects strong demand across businesses, indicating a healthy pipeline, though specific order book details are not disclosed.
Capex plans
Yes- →Minimal Capex planned over the next two years to contain significant capital expenditure.
- →Recent investments have created substantial headroom to scale specialty films sales to close to 90% without major new Capex.
- →On the Plastech side, capacity to be expanded by 50% with minimal Capex, enabling revenue growth from Rs. 100 crores to Rs. 200-250 crores by next year.
- →Incremental Capex is directed primarily at specialty assets, including development and launch of new specialty films and products.
- →Existing specialty business has sufficient capacity; new capacity added recently supports growth targets.
- →No major capacity constraints for specialty films; focus is on scaling existing value-added assets.
- →The company aims to reduce corporate net debt substantially in the next 2 years while improving ROCE and EBITDA, indicating capital discipline.
How does Cosmo First rank vs peers in Industrial Products?
Pro feature1Cosmo First
Rev 2Mar 1
See full Industrial Products sector rankings
How does Cosmo First rank in Industrial Products?
Compare Cosmo First against every Industrial Products company (Q1 FY27) on revenue, margins and earnings-call signals.